Hangzhou Coco Healthcare Products Co.,Ltd. (SHE:301009)
China flag China · Delayed Price · Currency is CNY
8.47
-0.39 (-4.40%)
Sep 15, 2026, 3:00 PM CST

SHE:301009 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
2.1236.1231.1720.18-43.1339.75
Depreciation & Amortization
62.7661.658.5756.8461.2549.43
Other Amortization
4.634.864.614.785.535.34
Loss (Gain) From Sale of Assets
0.10.10.040.1-0.12-0.04
Asset Writedown & Restructuring Costs
13.750.010.2113.8662.30.16
Loss (Gain) From Sale of Investments
-8.26-11.420.383.34-0.24-5.05
Provision & Write-off of Bad Debts
--0.710.84-3.485.21-2.07
Other Operating Activities
44.3731.915.312.08-17.2716.79
Change in Accounts Receivable
-17.6828.17-44.8455.6-30.95114.13
Change in Inventory
-14.33-10.24-39.4657.89-40.23-34.04
Change in Accounts Payable
29.24-13.0536.9418.38-33.46-137.69
Operating Cash Flow
111.39126.7652.44227.7-37.250.53
Operating Cash Flow Growth
43.24%141.71%-76.97%---87.24%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-72.5-39.88-75.35-66.01-116.4-240.45
Sale of Property, Plant & Equipment
0.090.064.440.690.610.47
Investment in Securities
-139.7960-260-10.56-120
Other Investing Activities
4.095.062.442.643.655.06
Investing Cash Flow
-208.1125.24-328.47-73.25-112.14-114.92

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-348.94100.013.05-50
Total Debt Issued
457.96348.94100.013.05-50
Short-Term Debt Repaid
--249.25----149.1
Long-Term Debt Repaid
--3.32-4.26-2.76-0.84-2.25
Lease Payments
--3.32-4.26-2.76-0.84-2.25
Total Debt Repaid
-348.69-252.57-4.26-2.76-0.84-151.35
Net Debt Issued (Repaid)
109.2796.3795.740.3-0.84-101.35
Issuance of Common Stock
-----761.55
Repurchase of Common Stock
---49.69---
Common Dividends Paid
-33.53-20.23-20.14--19.03-0.88
Other Financing Activities
26.7531.251.160.1-3024.5
Financing Cash Flow
102.49107.3927.070.4-49.87683.82

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-29.93-11.596.212.144.24-2.65
Net Cash Flow
-24.15247.8-242.75156.99-194.97616.78

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
38.8986.88-22.91161.69-153.6-189.92
Free Cash Flow Growth
13.51%-----
Free Cash Flow Margin
3.28%7.55%-2.12%14.95%-12.95%-16.01%
Free Cash Flow Per Share
0.150.34-0.090.56-0.57-0.81
Levered Free Cash Flow
15.7234.82-36.99131.04-266.81-285.95
Unlevered Free Cash Flow
15.7236.23-36.54131.44-266.64-285.35
Free Cash Flow After Leases
38.8983.56-27.18158.94-154.44-192.17

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
--12.26-25.17-12.13-60.14-10.59
Change in Working Capital
-8.084.28-48.67129.99-110.75-53.78